For information only. Not investment advice, a recommendation, an offer or a solicitation, and without regard to any recipient’s objectives or circumstances. Figures come from third-party sources believed reliable but not guaranteed, and market data may be delayed. Past performance is not a reliable indicator of future results. | ||||||||||||||||||||||||||||||||||||||||||||||||||
![]() Molina Healthcare, Inc.MOH US · Health Care · USD Current price$205.15as of Nov 20, 2026 Summary
Analyst consensusBuy 3Hold 15Strong Sell 117 analysts 3-year price (USD)Factor profileMulti-factor score 30 / 100 Market data
Business descriptionPure-play government-sponsored managed care: Medicaid (about 75% of 2025 premium revenue, the highest in the peer group), plus ACA Marketplace and Medicare. Sub-industry: Managed Health Care; Mid-Cap Blend. Competitive moatMedicaid specialist with state contracts, but lacks the integrated PBM, provider networks and analytics that help peers contain costs. CFRA sees less near-term visibility than less Medicaid-exposed peers. Recent developments
Investment risks / red flags
Financials
Classification
|
Last updated: Nov 13, 2026
Current price: $205.15 · Nov 20, 2026· USD
CFRA Ratinghold
TBI Multi Score30
Loading graph…
Factor Profile (Spider Chart)
TBI ModelPrice Chart (TradingView)
Symbol: MOHBusiness description
Pure-play government-sponsored managed care: Medicaid (about 75% of 2025 premium revenue, the highest in the peer group), plus ACA Marketplace and Medicare. Sub-industry: Managed Health Care; Mid-Cap Blend.
Competitive moat
Medicaid specialist with state contracts, but lacks the integrated PBM, provider networks and analytics that help peers contain costs. CFRA sees less near-term visibility than less Medicaid-exposed peers.
Recent developments
- Q3 2026: management points to an apparent plateau in medical cost trend and strong 2027 rate updates; CFRA reads 2026 as a trough year for Medicaid margins. Nine-month Medicaid MCR 92.6% (+140 bps Y/Y).
- New Medicaid contracts in Georgia and Texas delayed, pushing about USD 1.3B of premium revenue to later in 2027 or 2028.
- Portfolio pruning: ACA footprint cut to 7 states in 2027 (from 14); exit from MAPD for 2027. Guides Medicaid membership -6% in 2027 and -2-3% a year over 2027-2029.
- Sector read: Managed Health Care Q3 2026 Earnings & Post-Midterm Policy.
Investment risks / red flags
- OBBBA work requirements (no later than 12/31/2026), more frequent eligibility reviews and expiry of enhanced ACA subsidies.
- Cost trend (about 5.5% in 2026) outrunning pricing (about 4.5%).
- Valuation leans on a steep 2027 earnings rebound (+81%).
Market Data
Source: mkts.io · Nov 20, 2026, 16:01 UTC
Key Metrics
P/E (Fwd)21.24
Dividend0.00%
Beta0.74
52W High$244.89
52W Low$121.06
Analyst Consensus
3
15
Buy3Hold15Strong Sell117 analysts
Consensus Target$219.53
+7.0% upside
Calendar Events
Next EarningsOct 21, 2026
Financials
Revenue$42.08B
Rev Growth-3.50%
Earnings Growth-51.50%
Gross Margin8.35%
Op Margin0.64%
Profit Margin-0.11%
EBITDA$352.00M
ROA1.07%
ROE-1.15%
Rev/Share$825.10
Total Cash$8.58B
Total Debt$3.95B
D/E Ratio95.07
Free Cash Flow$416.38M
Op Cash Flow$331.00M
Current Ratio1.69
Forward Estimates
| Period | EPS Est | Rev Est |
|---|---|---|
| 0q | 0.51 | $11.94B |
| +1q | 3.08 | $11.76B |
| 0y | 5.27 | $44.74B |
| +1y | 9.54 | $47.63B |
Earnings
Quarterly EPS
4Q2025
Est: 0.33-2.75Miss
1Q2026
Est: 1.912.35Beat
2Q2026
Est: 1.401.51Beat
3Q2026
Est: 0.790.89Beat
Annual
2022
Rev $31.97BEarn $792.00M
2023
Rev $34.07BEarn $1.09B
2024
Rev $40.65BEarn $1.18B
2025
Rev $45.43BEarn $472.00M
Rating Changes
| Date | Firm | Action | To |
|---|---|---|---|
| Oct 27, 2026 | JP Morgan | main | Neutral |
| Oct 23, 2026 | UBS | main | Neutral |
| Oct 23, 2026 | Morgan Stanley | main | Equal-Weight |
| Oct 23, 2026 | RBC Capital | main | Sector Perform |
| Oct 23, 2026 | Barclays | main | Underweight |
| Jul 28, 2026 | Wells Fargo | main | Equal-Weight |
